MINNEAPOLIS--(BUSINESS WIRE)--Medtronic, Inc. (NYSE:MDT) announced today it has received a Medical Device License from Health Canada to sell its Melody™ Transcatheter Pulmonary Valve and Ensemble™ Transcatheter Delivery System.(a) The system is the first of its kind in North America to treat patients with congenital and acquired structural heart disease requiring pulmonary valve replacement.
